The purpose of this acquisition is to purchase exosome extraction for future RNA sequencing services for nhgri.
Ended Purchase Order Awarded Last action
- Contract number
- 75N92021P00271
- Awardee
-
Norgen Biotek Corp UEI SB5ZH66FTV27
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $119,200
Award facts
- Opportunity
-
- The purpose of this acquisition is to purchase Exo Solicitation · 75N92021Q0185 · Posted Jul 27, 2021
- The purpose of this acquisition is to purchase Exo Award Notice · Posted Aug 6, 2021
- Contract value 100% obligated
- $119,200.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $119,200 |
About this award
The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Heart, Lung and Blood Institute.
Quick answers
Who was awarded contract 75N92021P00271?
75N92021P00271 was awarded to Norgen Biotek Corp by National Heart Lung and Blood Institute (National Institutes of Health) on August 6, 2021.
How much is contract 75N92021P00271 worth?
The government has obligated $119,200 on 75N92021P00271.
Which agency awarded contract 75N92021P00271?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021P00271, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92021P00271 competed?
The extent of competition for 75N92021P00271 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award